Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Equillium (0A4D) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GB:0A4DEquillium$1.13$90.56M-6.243.76%Strong BuyUnlock the GB:0A4D analyst price target with TipRanks PremiumGB:0A4DUnlock the GB:0A4D top-analyst price target with TipRanks Premium
NRXPNRX Pharmaceuticals$2.80$124.12M-5.3522.81%Strong BuyUnlock the NRXP analyst price target with TipRanks PremiumGB:0A4D vs NRXPUnlock the NRXP top-analyst price target with TipRanks Premium
STROSutro Biopharma$8.50$141.11M-0.67-4.49%Strong BuyUnlock the STRO analyst price target with TipRanks PremiumGB:0A4D vs STROUnlock the STRO top-analyst price target with TipRanks Premium
HYFTMindWalk Holdings$0.90$42.82M-3.53-48.86%Strong BuyUnlock the HYFT analyst price target with TipRanks PremiumGB:0A4D vs HYFTUnlock the HYFT top-analyst price target with TipRanks Premium
PRLDPrelude Therapeutics$3.30$263.35M-5.0896.43%Strong BuyUnlock the PRLD analyst price target with TipRanks PremiumGB:0A4D vs PRLDUnlock the PRLD top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GB:0A4DEquillium1.130.043.76%
NRXPNRX Pharmaceuticals2.800.6731.46%
STROSutro Biopharma8.50-0.60-6.59%
HYFTMindWalk Holdings0.90-0.91-50.28%
PRLDPrelude Therapeutics3.301.6397.60%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts